Merck & Co. at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Merck & Co. brings 3 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 1108. The drugmaker's posters are real-world studies of triple-negative and other high-risk breast cancer: patient characteristics, treatment sequences and outcomes, including in older patients.

OrganizationSABCS 2026 Attendance
Merck & Co.
Rahway, NJ
Pharma
Global drugmaker with one of the largest oncology development programs, spanning more than 30 tumor types, including immunotherapy for triple-negative breast cancer.
Booth
Exhibiting at Booth 1108
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
5–6:30pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Merck & Co.

Tell us what you sell and we’ll find the people at Merck & Co. most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction